On May 7, 2025, Gilead Sciences, Inc. held its Annual Meeting where stockholders elected nine directors and ratified Ernst & Young as auditors for 2025. Notably, several shareholder proposals regarding executive compensation and governance were rejected, with significant support for the election outcomes.